Subjects with a combined elevation of baseline CRP and TNF-α levels indicated a significantly increased risk of developing T2DM (OR = 4.11, 95% CI: 1.10-15.33, P = 0.035) when compared with the low-level group in the adjusted analysis. The gene discussed is CRP; the disease is type 2 diabetes mellitus.